BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26569085)

  • 21. Management of pulmonary arterial hypertension.
    McLaughlin VV; Shah SJ; Souza R; Humbert M
    J Am Coll Cardiol; 2015 May; 65(18):1976-97. PubMed ID: 25953750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current therapies for pulmonary arterial hypertension.
    Takaoka S; Faul JL; Doyle R
    Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for the prognosis of pulmonary arterial hypertension: Holy Grail or flying circus?
    Lador F; Soccal PM; Sitbon O
    J Heart Lung Transplant; 2014 Apr; 33(4):341-3. PubMed ID: 24439967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
    Humbert M; Lau EMT
    Am J Respir Crit Care Med; 2021 Mar; 203(6):675-677. PubMed ID: 33357026
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary arterial hypertension: epidemiology and registries.
    McGoon MD; Benza RL; Escribano-Subias P; Jiang X; Miller DP; Peacock AJ; Pepke-Zaba J; Pulido T; Rich S; Rosenkranz S; Suissa S; Humbert M
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D51-9. PubMed ID: 24355642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macitentan and morbidity and mortality in pulmonary arterial hypertension.
    Pulido T; Adzerikho I; Channick RN; Delcroix M; Galiè N; Ghofrani HA; Jansa P; Jing ZC; Le Brun FO; Mehta S; Mittelholzer CM; Perchenet L; Sastry BK; Sitbon O; Souza R; Torbicki A; Zeng X; Rubin LJ; Simonneau G;
    N Engl J Med; 2013 Aug; 369(9):809-18. PubMed ID: 23984728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful pregnancy in a patient with idiopathic pulmonary arterial hypertension. Case report].
    Szenczi O; Karlócai K; Bucsek L; Rigó J
    Orv Hetil; 2016 Apr; 157(15):593-5. PubMed ID: 27039998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic lupus erythematosus associated pulmonary arterial hypertension: clinical analysis of 91 cases].
    Teng J; Zhang W
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):969-72. PubMed ID: 24851680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary arterial hypertension in children: new therapeutic approaches].
    Beghetti M
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):570-5. PubMed ID: 17524605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [International competitive clinical research].
    Vogelmeier CF
    Dtsch Med Wochenschr; 2016 Nov; 141(24):1734. PubMed ID: 27903021
    [No Abstract]   [Full Text] [Related]  

  • 32. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and future therapeutic targets for pulmonary arterial hypertension.
    Fraidenburg D; Yuan J
    High Alt Med Biol; 2013 Jun; 14(2):134-43. PubMed ID: 23795733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New treatments of pediatric pulmonary hypertension].
    Wacker J; Tissot C; Beghetti M
    Rev Med Suisse; 2012 Feb; 8(329):423-7. PubMed ID: 22432244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary arterial hypertension.
    McLaughlin VV; Davis M; Cornwell W
    Curr Probl Cardiol; 2011 Dec; 36(12):461-517. PubMed ID: 22035608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
    Bishop BM; Mauro VF; Khouri SJ
    Pharmacotherapy; 2012 Sep; 32(9):838-55. PubMed ID: 22806762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.
    del Cerro Marín MJ; Sabaté Rotés A; Rodriguez Ogando A; Mendoza Soto A; Quero Jiménez M; Gavilán Camacho JL; Raposo Sonnenfeld I; Moya Bonora A; Albert Brotons DC; Moreno Galdó A;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1421-9. PubMed ID: 25379685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.
    Foster WS; Suen CM; Stewart DJ
    Can J Cardiol; 2014 Nov; 30(11):1350-60. PubMed ID: 25442435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of two predictive models for survival in pulmonary arterial hypertension.
    Sitbon O; Benza RL; Badesch DB; Barst RJ; Elliott CG; Gressin V; Lemarié JC; Miller DP; Muros-Le Rouzic E; Simonneau G; Frost AE; Farber HW; Humbert M; McGoon MD
    Eur Respir J; 2015 Jul; 46(1):152-64. PubMed ID: 25837032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcoidosis-associated pulmonary hypertension.
    Cordova FC; D'Alonzo G
    Curr Opin Pulm Med; 2013 Sep; 19(5):531-7. PubMed ID: 23912192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.